An observation study on the long-term efficacy of Huisheng oral solution after radical operation of stage II to IIIb non-small cell lung cancer (NSCLC)

Phase 4

Recruiting

• Conditions: on-small cell lung cancer(NSCLC)

• Registration Number: ITMCTR2100004907
• Lead Sponsor: Sichuan Provincial People's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. The patient's aged >=18 years, and the gender is not limited;
2. Radical surgical treatment has been performed in the research center (Thoracic Surgery Department of Sichuan Provincial People's Hospital);
3. On the 5 ± 3 days after the operation, pathological examination was diagnosed as non-small cell lung cancer, and according to the 8th edition of the International Society for the Study of Lung Cancer (IASLC) lung cancer TNM staging was stage II to IIIb;
4. The investigator assessed complete remission (CR) after the operation;
5. No history of allergies to the ingredients of Huisheng Oral Liquid in the past;
6. Performance Status: 0-1 points;
7. The life expectancy is at least 12 weeks;
8. Laboratory examinations confirmed that the patient's blood routine and liver and kidney functions were normal within 7 days before the first medication;
9. The patient must have the ability to understand and voluntarily sign an informed consent form.

Exclusion Criteria

1. Merge other tumors;
2. Those with a history of deep vein thrombosis, pulmonary embolism, stroke, acute myocardial infarction, atrial fibrillation, patent foramen ovale, etc.;
3. Patients with bleeding tendency or coagulation disorders;
4.6 Those who have suffered acute spinal cord injury, have undergone joint replacement surgery, and have multiple traumas to hip, pelvic or lower limb fractures within 4.6 months;
5. Suffer from uncontrollable neurological, mental illness or mental disorder, and poor compliance;
6. Patients who participate in other clinical trials at the same time;
7. Other situations that the researcher thinks are not suitable for inclusion in the group.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified